- The Washington Times - Tuesday, March 20, 2007

ASSOCIATED PRESS

More than 5 million Americans are living with Alzheimer’s disease a 10 percent increase since the last Alzheimer’s Association estimate five years ago and that increase seems to support the long-forecast dementia epidemic as the population grays.

Age is the biggest risk factor, and the report released yesterday shows that the nation is on track for skyrocketing Alzheimer’s once the baby boomers start turning 65 in 2011. Already, one in eight persons 65 and older have the mind-destroying illness, and nearly one in two persons older than 85.

Unless scientists discover a way to delay Alzheimer’s brain attack, about 7.7 million people are expected to have the disease by 2030, the report says. By 2050, that toll could reach 16 million.

Why? Ironically, in fighting heart disease, cancer and other diseases, “we’re keeping people alive so they can live long enough to get Alzheimer’s disease,” said association Vice President Steve McConnell.

Indeed, government figures released last year show small drops in deaths from most of the nation’s leading killers between 2000 and 2004 even as deaths attributed to Alzheimer’s disease increased 33 percent.

Yet the report also contains a startling finding: From 200,000 to 500,000 people younger than 65 have either early-onset Alzheimer’s or another form of dementia. Researchers have been hard-pressed to estimate the number of young sufferers.

“I think this has been drastically underreported,” said Bill Thies, the Alzheimer’s Association’s medical director.

He cites as an example a 55-year-old having problems at work, such as behavior changes or missing deadlines, that may be early signs of brain impairment but that go unrecognized until they progress to full-scale memory problems.

The report based on federal population counts, not new disease research is the first update of the Alzheimer’s toll since 2002, when it was estimated to afflict 4.5 million people. It is being released as Congress considers funding for research into Alzheimer’s and other diseases.

No one knows what causes Alzheimer’s creeping brain degeneration. It gradually robs sufferers of their memories and ability to care for themselves, eventually killing them. There is no known cure, and drug treatments only temporarily alleviate symptoms.

The report shows Medicare spends nearly three times as much for dementia patients’ care as for the average beneficiary $13,207 a year versus $4,454 because the disease complicates treatment for every other illness. Medicare’s spending on dementia-related care is projected to double to more than $189 million by 2015.

That doesn’t include the value of the unpaid round-the-clock care that families and friends provide the vast majority of Alzheimer’s patients who live at home a tab the report calculates at almost $83 billion or nursing home costs.

Nine drugs are in late-stage clinical trials, including a few that aim to slow Alzheimer’s worsening. If such drugs pan out, delaying Alzheimer’s symptoms by even a few years could cut by millions the coming decades’ predicted toll, the report notes.


Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide